Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement

Background. Adalimumab (ADA) is effective for patients with Crohn's disease (CD). However, there have been few reports on ADA therapy with respect to its relationship with pathologic findings and drug efficacy in biologically naïve CD cases. Methods. Fifteen patients with active biologically na...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizoshita, Tsutomu, Tanida, Satoshi, Tsukamoto, Hironobu, Ozeki, Keiji, Katano, Takahito, Nishiwaki, Hirotaka, Ebi, Masahide, Mori, Yoshinori, Kubota, Eiji, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009194/
https://www.ncbi.nlm.nih.gov/pubmed/24829572
http://dx.doi.org/10.1155/2014/687257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009194/
https://www.ncbi.nlm.nih.gov/pubmed/24829572
http://dx.doi.org/10.1155/2014/687257

Ejemplares similares